RYAVX
Price
$74.74
Change
+$0.71 (+0.96%)
Updated
Nov 18 closing price
Net Assets
5.13M
VISVX
Price
$48.44
Change
+$0.14 (+0.29%)
Updated
Nov 18 closing price
Net Assets
58.35B
Interact to see
Advertisement

RYAVX vs VISVX

Header iconRYAVX vs VISVX Comparison
Open Charts RYAVX vs VISVXBanner chart's image
Rydex S&P MidCap 400 Pure Value H
Price$74.74
Change+$0.71 (+0.96%)
VolumeN/A
Net Assets5.13M
Vanguard Small Cap Value Index I
Price$48.44
Change+$0.14 (+0.29%)
VolumeN/A
Net Assets58.35B
RYAVX vs VISVX Comparison Chart in %
View a ticker or compare two or three
VS
RYAVX vs. VISVX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYAVX is a Hold and VISVX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 58.3B vs. RYAVX (5.13M). VISVX pays higher dividends than RYAVX: VISVX (1.90) vs RYAVX (0.00). RYAVX was incepted earlier than VISVX: RYAVX (22 years) vs VISVX (28 years). RYAVX (1.61) is less costly to investors than VISVX (0.19). RYAVX is a more actively managed with annual turnover of: 3996.00 vs. VISVX (16.00). RYAVX has a lower initial minimum investment than VISVX: RYAVX (2500) vs VISVX (3000). VISVX annual gain was more profitable for investors over the last year : -2.33 vs. RYAVX (-6.77). VISVX return over 5 years is better than : 55.12 vs. RYAVX (44.84).
RYAVXVISVXRYAVX / VISVX
Total Expense Ratio1.560.19821%
Annual Report Gross Expense Ratio1.610.19847%
Fund Existence22 years28 years-
Gain YTD1.4251.97172%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets5.13M58.3B0%
Annual Yield % from dividends0.001.90-
Returns for 1 year-6.77-2.33291%
Returns for 3 years6.3423.9426%
Returns for 5 years44.8455.1281%
Returns for 10 years77.63103.5075%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTKB5.530.24
+4.63%
Cytek Biosciences
SPRO2.460.03
+1.44%
Spero Therapeutics
ALHC16.090.05
+0.31%
Alignment Healthcare
BRTX1.24N/A
N/A
BioRestorative Therapies
AWK129.91-2.77
-2.09%
American Water Works Company